Physician profile
David A Marks
NPI 1821016023
$452,503.53
in general payments reported to CMS, 2019-2025
58 companies · $107K in 2025
The $107K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $19K · 2021: $28K · 2022: $25K · 2023: $91K · 2024: $165K · 2025: $107K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $302K · Travel and Lodging: $40K · Food and Beverage: $15K · Education: $5,771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $302,300.00 |
| Travel and Lodging | $40,399.59 |
| Food and Beverage | $14,802.09 |
| Education | $5,771.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $392,370.88 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $35,528.28 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Intuitive Surgical, INC. | $6,942.18 | 2024-2025 | |
| Inspire Medical Systems, INC. | $4,929.44 | 2024-2025 | Inspire |
| Mallinckrodt Hospital Products INC. | $2,819.20 | 2020-2025 | Acthar |
| Bayer Healthcare Pharmaceuticals INC. | $1,204.85 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $1,019.28 | 2019-2024 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $962.04 | 2019-2025 | Ofev, Jascayd |
| Pulmonx Corporation | $878.52 | 2019-2024 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Hill-Rom Company, INC | $875.00 | 2021 | |
| Grifols USA, LLC | $632.00 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Regeneron Healthcare Solutions, INC. | $588.95 | 2019-2025 | Dupixent |
| Merz North America, INC. | $296.09 | 2023 | |
| Jazz Pharmaceuticals INC. | $266.51 | 2019-2025 | |
| Mylan Specialty L.P. | $229.82 | 2019-2022 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $217.97 | 2021-2024 | Glassia |
| Shire North American Group INC | $185.86 | 2019 | |
| Axsome Therapeutics, INC. | $176.83 | 2024-2025 | Sunosi |
| Electromed, INC. | $174.29 | 2019-2025 | Smartvest |
| Zoll Respicardia, INC. | $161.37 | 2024 | Remede System |
| Genzyme Corporation | $145.13 | 2019-2025 | |
| United Therapeutics Corporation | $143.48 | 2019-2025 | Tyvaso, Tyvaso |
| Organogenesis INC. | $130.13 | 2022-2023 | Puraply |
| Harmony Biosciences LLC | $125.21 | 2021-2025 | |
| Verona Pharma, INC. | $124.98 | 2025 | Ohtuvayre |
| Phadia US INC. | $116.02 | 2024-2025 | Immunocap |
| Insmed, INC. | $115.04 | 2019-2025 | Arikayce, Brinsupri |
| Vifor Pharma, INC. | $114.35 | 2024 | Zemaira, Veltassa |
| Biofire Diagnostics, LLC | $90.01 | 2019 | |
| Baxter Healthcare | $87.26 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Ani Pharmaceuticals, INC. | $86.54 | 2024-2025 | Purified Cortrophin Gel |
| Tactile Systems Technology INC | $85.31 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Janssen Pharmaceuticals, INC | $70.23 | 2019-2021 | |
| Fisher & Paykel Healthcare INC | $66.79 | 2024 | Fisher & Paykel Healthcare |
| Philips North America LLC | $61.97 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $60.12 | 2019 | |
| Advanced Respiratory, INC | $54.39 | 2020 | |
| Amgen INC. | $49.93 | 2024 | Tezspire |
| Viatris Specialty LLC | $39.03 | 2025 | Yupelri |
| Paratek Pharmaceuticals, INC. | $38.98 | 2021-2022 | |
| Circassia INC. | $35.78 | 2019-2024 | Niox |
| Genentech USA, INC. | $34.40 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $29.36 | 2024 | Winrevair |
| Novartis Pharmaceuticals Corporation | $23.31 | 2019 | |
| Gilead Sciences, INC. | $21.44 | 2019 | |
| Itamar Medical INC | $21.04 | 2022 | |
| Idorsia Pharmaceuticals US INC | $19.83 | 2024 | Quviviq |
| Optinose US, INC. | $15.34 | 2019 | |
| Pharming Healthcare, INC. | $13.62 | 2025 | Ruconest |
| Boston Scientific Corporation | $12.79 | 2019 | |
| Apria Healthcare LLC | $12.36 | 2021 |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.